📋 CymaBay Therapeutics, Inc. (CBAY) - Regulatory Update
Filing Date: 2022-06-14
Accepted: 2022-06-14 16:04:33
Event Type: Regulatory Update
Event Details:
CymaBay Therapeutics (was acquired by Gilead Sciences, Inc. (Nasdaq: GILD) on 12/02/2024) (CBAY) Announces Regulatory Update
CymaBay Therapeutics (was acquired by Gilead Sciences, Inc. (Nasdaq: GILD) on 12/02/2024) (CBAY) provided an update on regulatory developments for its product portfolio.
Regulatory Update Details:
None
Clinical Development:
💼 Business Developments:
Partnership: Not available
Acquisition: Not available
Licensing: Not available
Regulatory Approval
Executive Changes: Not available
Structured Data:
Company Name: CymaBay Therapeutics (was acquired by Gilead Sciences, Inc. (Nasdaq: GILD) on 12/02/2024)
📋 CymaBay Therapeutics, Inc. (CBAY) - Regulatory Update
Filing Date: 2022-06-14
Accepted: 2022-06-14 16:04:33
Event Type: Regulatory Update
Event Details:
💼 Business Developments:
Structured Data: